drugset / Trial / NCT02049073

Prevention of Noise-induced Hearing Loss

NCT02049073

Non-randomizedParallel-groupOpen-labelPrevention

Summary

Noise-induced hearing loss affects an estimated 5% of the worldwide population, with 30-40 million Americans exposed to hazardous sound or noise levels regularly. Sources of noise may be occupational, blast noise, or recreational. Trauma to the inner ear can occur through transient hearing loss or permanent hearing loss. Although hearing recovers after temporary transient hearing loss, growing evidence suggests that repeated temporary transient hearing loss may lead to a permanent hearing loss. Currently, there are no treatments and there are no known medications that can be used clinically to prevent noise-induced hearing loss in humans. The long-term goal of this research is to find medications that can prevent noise-induced hearing loss. The purpose of the present pilot study is to evaluate zonisamide and methylprednisolone as medications to prevent temporary transient hearing loss in humans.

Timeline

Start
2017-10-31
Primary completion
2017-11-01
Completion
2017-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 32 mg Oral
Subject Methylprednisolone Other / unclassified 64 mg Oral
Subject Zonisamide Other / unclassified 100 mg Oral
Subject Zonisamide Other / unclassified 200 mg Oral